Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1416243-42-9 | 10-([1,1'-Biphenyl]-4-yl)anthracen-9-yl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | AA00A1EQ | MFCD31618120
142457-00-9 | AMTHAMINE DIHYDROBROMIDE | AA00A3OC | MFCD00673891
1212466-82-4 | 4-BROMO-1H-PYRAZOLE-5-CARBOXALDEHYDE DIMER | AA00A5UV | MFCD08445454
1211573-00-0 | N,N-DiMethyl-3-pyrrolidinecarboxaMide HCl | AA00A9VC | MFCD17214731
1361115-18-5 | N-Methyl-3-pyrrolidinecarboxamide hydrochloride | AA00AARF | MFCD21605763
16680-47-0 | Sodium (9S,13S,14S)-13-methyl-17-oxo-9,11,12,13,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate | AA00AB3H | MFCD00468047
147027-04-1 | 1,3-OXATHIOLANE-2-CARBOXYLIC ACID, 5-HYDROXY-, TRANS- | AA00ABCJ | MFCD08460633
1532533-67-7 | Rp-5264 | AA00ABJ4 | MFCD28386165
1628428-01-2 | Pkr-in-2 | AA00ABMZ | MFCD29472293
181811-46-1 | 1-(Benzo[d]oxazol-2-yl)piperidine-4-carboxylic acid | AA00ABUZ | MFCD03830245